Aion Therapeutic Inc. (ANTCF)

Aion Therapeutic Income Statement

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 31, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Revenue	1.47	0.37	-	-	-	-
Cost of Revenue	1	0.2	-	-	0	-
Gross Profit	0.48	0.16	-	-	-0	-
Selling, General & Admin	1.88	1.26	0.84	1.37	2	0.85
Research & Development	-	-	-	0.95	-	-
Operating Expenses	2	1.3	0.86	2.39	2.6	0.96
Operating Income	-1.52	-1.14	-0.86	-2.39	-2.6	-0.96
Interest Expense	-0.33	-0.17	-0.15	-0.08	-0.19	-0.32
Interest & Investment Income	0	0.01	-	-	-	-
Earnings From Equity Investments	-0.01	-0.01	-0.11	-	-	-
Currency Exchange Gain (Loss)	0.15	-0.05	0.17	0.08	-0.17	-
Other Non Operating Income (Expenses)	-0.06	-0.05	-0.12	-0.43	-0.17	-0.03
EBT Excluding Unusual Items	-1.77	-1.41	-1.07	-2.82	-3.13	-1.32
Impairment of Goodwill	-	-	-	-	-2.54	-
Asset Writedown	-2.01	-2.01	0.25	-1	-2.6	-
Other Unusual Items	-2.86	-2.86	0.56	-	-	0.65
Pretax Income	-6.65	-6.29	-0.26	-3.82	-8.27	-0.67
Net Income	-6.65	-6.29	-0.26	-3.82	-8.27	-0.67
Net Income to Common	-6.65	-6.29	-0.26	-3.82	-8.27	-0.67
Shares Outstanding (Basic)	460	265	146	140	94	36
Shares Outstanding (Diluted)	460	265	146	140	94	36
Shares Change (YoY)	129.87%	81.07%	4.65%	48.98%	161.64%	30.62%
EPS (Basic)	-0.01	-0.02	-0.00	-0.03	-0.09	-0.02
EPS (Diluted)	-0.01	-0.02	-0.00	-0.03	-0.09	-0.02
Free Cash Flow	-1.55	-0.85	-0.04	-1.35	-2.13	-0.76
Free Cash Flow Per Share	-0.00	-0.00	-	-0.01	-0.02	-0.02
Gross Margin	32.29%	44.39%	-	-	-	-
Operating Margin	-103.49%	-310.32%	-	-	-	-
Profit Margin	-451.18%	-1710.90%	-	-	-	-
Free Cash Flow Margin	-104.95%	-229.96%	-	-	-	-
EBITDA	-1.49	-1.13	-0.84	-2.33	-2.47	-0.85
D&A For EBITDA	0.03	0.01	0.02	0.07	0.13	0.11
EBIT	-1.52	-1.14	-0.86	-2.39	-2.6	-0.96
Advertising Expenses	-	0.05	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.